Synlogic (SYBX)
(Delayed Data from NSDQ)
$1.56 USD
-0.08 (-4.88%)
Updated Aug 8, 2024 12:53 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 61 - 80 ( 111 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1020 Discontinued; Reducing 12-Month Price Target to $13; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
2Q19 Financial Results Reported; Entering Immuno- Oncology; Solid Oral Bridging Work Beginning; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1618 Proof-of-Concept Data Encouraging; Reiterate Buy; Raising Target to $22
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Progress on Multiple Fronts; Ginkgo Bioworks Partnership Provides Solid Foundation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Synlogic and Gingko Kissing Under the Nissle-toe
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
1Q:19 Financials, Oral Formulation for ?1618 Forthcoming
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1618 Solid Oral Dosage Formulation Characterization Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Solid? Developments in SYNB1618 Product Formulation
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
FY18 Financials; Key SYNB1020 and SYNB1618 Datasets up Ahead Mid-2019
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
2018 Financial Results Reported; Lower-Than-Projected Spending; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R